Hot Products

Evodiamine
Catalog No: CFN99993

Evodiamine, a novel non-pungent vanilloid receptor agonist, which has the effects of anti-obese, analgesic, vasodilator, anti-oxidation, anti-inflammatory and anti-cancer. It prevents the accumulation of perivisceral fat and the body weight increase, blocks of the Ca2+ influx through receptor-mediated Ca2+ channels, inhibits NF-kB activation through suppression of IkB kinase activity.

Evodine
Catalog No: CFN90488

Evodine may have antinociceptive activity.

Evodol
Catalog No: CFN98214

Evodol may as an anti-inflammatory agent or lead compound, it shows inhibitory activity on nitric oxide (NO) production in lipopolysaccharide -activated RAW264.7 macrophages. Evodol and limonin possess larvicidal activity against the Asian tiger mosquitoes with LC50 values of 52.22 and 32.43 ug/ml, respectively.

Evofolin B
Catalog No: CFN99803

Evofolin B exhibits quinone reductase (QR) inducing activity, with observed CD (concentration required to double induction) values of 16.4 microM.

Evonimine
Catalog No: CFN92102

Reference standards.

Evonine
Catalog No: CFN92107

Evonine shows insecticidal activity against Mythimna separata, the LC50 value of 23.23 mg /mL.

Exoticin
Catalog No: CFN99417

Exoticin shows antinociceptive and neuropharmacological activities, it could be considered as a suitable candidate for the development of analgesic and anxiolytic agents.

Fabiatrin
Catalog No: CFN90807

Falcarindiol
Catalog No: CFN98220

Falcarindiol has antimutagenic, neuroprotective, antifungal, anti-bacterial, and anticancer activities, it could be potentially used in food manufactures and cosmetology as preservative agents and biopesticides, or in medicine as new antibiotics. Falcarindiol has protective effects against CCl(4) toxicity, in part, the effects might be explained by anti-lipid peroxidation activity associated with the induction of the GSTs including GSTA4.

Falcarinol
Catalog No: CFN96027

Falcarinol has effects on CaCo-2 cells appear to be biphasic, inducing pro-proliferative and apoptotic characteristics at low and high concentrations of Falcarinol, respectively. Falcarinol-associated dermatitis is due to antagonism of the CB(1) receptor in keratinocytes, leading to increased chemokine expression and aggravation of histamine action.